2021 | BioSenic

Bone Therapeutics strengthens its financial structure with the implementation of its financing agreement with the European Investment Bank

Read more about Bone Therapeutics strengthens its financial structure with the implementation of its financing agreement with the European Investment Bank

Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004

Read more about Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004

Bone Therapeutics reacts to the press release issued by Hybrigenics

Read more about Bone Therapeutics reacts to the press release issued by Hybrigenics

Bone Therapeutics reports half year 2021 results

Read more about Bone Therapeutics reports half year 2021 results

Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer

Read more about Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer

Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

Read more about Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

Read more about Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

Bone Therapeutics Provides Third Quarter 2021 Business Update

Read more about Bone Therapeutics Provides Third Quarter 2021 Business Update

Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

Read more about Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

Read more about Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

Subscribe to 2021